Skip to content
-
Subscribe to our newsletter & never miss our best posts. Subscribe Now!
Itfy.in

At Itfy, we are dedicated to revolutionizing the way you receive news. Our mission is to provide timely, accurate, and personalized news updates using cutting-edge AI technology. Stay informed, stay ahead with us.

Itfy.in

At Itfy, we are dedicated to revolutionizing the way you receive news. Our mission is to provide timely, accurate, and personalized news updates using cutting-edge AI technology. Stay informed, stay ahead with us.

  • Home
  • News Updates
    • Latest News
    • Entertainment News
    • Northeast News
  • Technology
    • Digital Transformation
    • Artificial Intelligence
    • Machine Learning
    • Generative AI
    • Cybersecurity
  • Education & Growth
    • Education
    • Lifelong Learning
    • Parenting
    • Career Growth
  • Startup & Entrepreneurship
    • Remote Work
    • Startups
    • Digital Marketing
    • Social Media
    • Entrepreneurship
    • Lean Thinking
    • Personal Finance
  • Climate Justice
    • Climate Tech
  • Health & Wellness
    • Mental Health
  • Tourism
  • Home
  • News Updates
    • Latest News
    • Entertainment News
    • Northeast News
  • Technology
    • Digital Transformation
    • Artificial Intelligence
    • Machine Learning
    • Generative AI
    • Cybersecurity
  • Education & Growth
    • Education
    • Lifelong Learning
    • Parenting
    • Career Growth
  • Startup & Entrepreneurship
    • Remote Work
    • Startups
    • Digital Marketing
    • Social Media
    • Entrepreneurship
    • Lean Thinking
    • Personal Finance
  • Climate Justice
    • Climate Tech
  • Health & Wellness
    • Mental Health
  • Tourism
Close

Search

  • https://www.facebook.com/
  • https://twitter.com/
  • https://t.me/
  • https://www.instagram.com/
  • https://youtube.com/
Subscribe
Home/Latest News/Breakthrough 5-in-1 Compound Beats Semaglutide: Diabetes & Weight Loss
Breakthrough 5-in-1 Compound Beats Semaglutide: Diabetes & Weight Loss
Latest News

Breakthrough 5-in-1 Compound Beats Semaglutide: Diabetes & Weight Loss

By adminitfy
May 3, 2026 2 Min Read

Researchers presented a novel experimental “five-in-one” compound at the European Association for the Study of Diabetes (EASD) 2025 Annual Meeting that combined five metabolic actions and produced stronger glucose control and weight loss than current therapies in early animal tests. Daniela Liskiewicz, PhD, of the Institute for Diabetes and Obesity at Helmholtz Zentrum München and the German Center for Diabetes Research reported that the engineered “quintuple agonist” links GLP‑1 and GIP receptor agonism with lanifibranor, a molecule that activates three PPAR receptors (PPAR‑alpha, PPAR‑delta and PPAR‑gamma), to target metabolism on multiple fronts.

The compound is designed to do more than mimic a single hormone: the GLP‑1 and GIP components act on appetite, insulin secretion and early post‑meal glucose responses, while the triple‑PPAR activity influences fat handling, energy use and long‑term insulin sensitivity. According to the researchers, combining these five mechanisms produces synergistic effects in the brain and adipose tissue that exceed the impact of giving each component separately.

That matters because current breakthrough drugs such as semaglutide (a GLP‑1 agonist) and tirzepatide (a dual GIP/GLP‑1 agonist) primarily reduce appetite, slow gastric emptying and boost insulin release-powerful effects but focused on one or two pathways. Liskiewicz noted, “PPARs are master regulators of metabolism expressed in key metabolic tissues,” underlining why adding PPAR activation could address deeper metabolic dysfunction.

Early studies in obese, insulin‑resistant mice showed the quintuple agonist produced greater reductions in blood glucose and body weight than even the most effective existing agents. Researchers caution, however, that these are preclinical proof‑of‑concept results: rigorous human trials are required to establish safety, dosing and long‑term benefits across diverse populations.

The work signals a shift toward multi‑target, precision approaches for diabetes and obesity treatment-promising, but still at an early stage. This report is informational and not a substitute for medical advice; patients should consult their doctors about treatment options.

Original Source: https://www.ndtv.com/health/beyond-glp-1-five-in-one-compound-more-effective-than-semaglutide-for-diabetes-and-weight-loss-11440894#publisher=newsstand
Category:
Tags:
Publish Date: 2026-05-03 00:26:00

Author

adminitfy

Follow Me
Other Articles
Groundbreaking National Conclave on Tech & Judicial Education Concludes
Previous

Groundbreaking National Conclave on Tech & Judicial Education Concludes

Next

Why Indian Athletes Flee Doping Control: Urgent Integrity Crisis

Search...

Recent Posts

  • Assam: Illegal Liquor Recovered in Morigaon’s Mairabari Eviction Drive
    Assam: Illegal Liquor Recovered in Morigaon’s Mairabari Eviction Drive
    by adminitfy
    November 19, 2026
  • Empowering Northeast India: CII’s CSR Connect Event Ignites Social Development
    by adminitfy
    July 3, 2024
  • Urgent Crisis: Northeast on High Alert as Death Toll Tragically Rises in Assam
    by adminitfy
    July 3, 2024
  • Triumphant Breakthrough: Security Forces Successfully Capture 4 Insurgents in Manipur Operation
    by adminitfy
    July 3, 2024

Welcome to the ultimate source for fresh perspectives! Explore curated content to enlighten, entertain and engage global readers.

  • Facebook
  • X
  • Instagram
  • LinkedIn

Latest Posts

  • Assam: Illegal Liquor Recovered in Morigaon’s Mairabari Eviction Drive
  • Emergency Powers and the Hidden Cost of Coal
  • Manipur’s Dr Thangjam Dhabali Singh Wins 17th O.N.E. India Award 2026
  • The Remarried Empress Episodes 7 & 8 Buzz: Release Date, Exact Time, Where to Watch & Must-Watch Episode Guide Unveiled
  • Manipur Governor, CM Pay Tribute to Slain Army Captain, Sepoy
  • November 2026 (597)
  • October 2026 (646)
  • September 2026 (524)
  • August 2026 (1001)
  • July 2026 (986)
  • June 2026 (963)
  • May 2026 (922)
  • April 2026 (1525)
  • March 2026 (1522)
  • February 2026 (1252)
  • January 2026 (968)
  • December 2025 (942)
  • November 2025 (853)
  • October 2025 (869)
  • September 2025 (733)
  • August 2025 (810)
  • July 2025 (720)
  • June 2025 (1244)
  • May 2025 (2201)
  • April 2025 (1481)
  • March 2025 (2020)
  • February 2025 (1159)
  • January 2025 (1440)
  • December 2024 (1499)
  • November 2024 (1771)
  • October 2024 (1815)
  • September 2024 (1750)
  • August 2024 (1458)
  • July 2024 (1268)

Contact

Email

info@itfy.in

Location

INDIA

Copyright 2026 — Itfy.in. All rights reserved.